Patents by Inventor Philip Iredale

Philip Iredale has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pharmaceutical composition for the prevention and treatment of addiction in a mammal
    Publication number: 20050043327
    Abstract: Pharmaceutical compositions are disclosed for the treatment of alcohol or cocaine dependence or addiction, tobacco dependence or addiction, reduction of alcohol withdrawal symptoms or aiding in the cessation or lessening of alcohol use or substance abuse or other behavioral dependencies including gambling. The pharmaceutical compositions are comprised of a therapeutically effective combination of an opioid receptor antagonist and a CB-1 receptor antagonist and a pharmaceutically acceptable carrier. The method of using these compounds is also disclosed.
    Type: Application
    Filed: June 17, 2004
    Publication date: February 24, 2005
    Inventors: Jotham Coe, Philip Iredale, Stanton McHardy, Stafford McLean
  • Pharmaceutical composition for the prevention and treatment of addiction in a mammal
    Publication number: 20050043345
    Abstract: Pharmaceutical compositions are disclosed for the treatment of alcohol or cocaine dependence or addiction, tobacco dependence or addiction, reduction of alcohol withdrawal symptoms or aiding in the cessation or lessening of alcohol use or substance abuse or other behavioral dependencies including gambling. The pharmaceutical compositions are comprised of a therapeutically effective combination of an opioid receptor antagonist and an alpha2delta ligand and a pharmaceutically acceptable carrier. The method of using these compounds is also disclosed.
    Type: Application
    Filed: June 17, 2004
    Publication date: February 24, 2005
    Inventors: Jotham Coe, Philip Iredale, Stanton McHardy, Stafford McLean